MV Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $68.3M | Buy |
271,250
+688
| +0.3% | +$148K | 6.05% | 4 |
|
|
2026
Q1 | $58.8M | Sell |
270,562
-179
| -0.1% | -$39.7K | 5.77% | 4 |
|
|
2025
Q4 | $61.9M | Buy |
270,741
+226
| +0.1% | +$51.5K | 5.94% | 4 |
|
|
2025
Q3 | $62.6M | Sell |
270,515
-94
| -0% | -$19.1K | 6.01% | 4 |
|
|
2025
Q2 | $50.2M | Sell |
270,609
-414
| -0.2% | -$76.9K | 5.17% | 4 |
|
|
2025
Q1 | $56.8M | Buy |
271,023
+4,339
| +2% | +$844K | 6.09% | 4 |
|
|
2024
Q4 | $47.4M | Buy |
266,684
+81
| +0% | +$14.9K | 5.06% | 4 |
|
|
2024
Q3 | $52.6M | Buy |
266,603
+993
| +0.4% | +$185K | 5.59% | 4 |
|
|
2024
Q2 | $45.6M | Buy |
265,610
+84
| +0% | +$13.9K | 5.12% | 4 |
|
|
2024
Q1 | $48.4M | Buy |
265,526
+536
| +0.2% | +$92.4K | 5.53% | 4 |
|
|
2023
Q4 | $41.1M | Buy |
264,990
+80
| +0% | +$11.7K | 5.2% | 4 |
|
|
2023
Q3 | $39.5M | Buy |
264,910
+450
| +0.2% | +$66.1K | 5.27% | 4 |
|
|
2023
Q2 | $35.6M | Sell |
264,460
-2,247
| -0.8% | -$330K | 4.73% | 5 |
|
|
2023
Q1 | $42.5M | Buy |
266,707
+39,660
| +17% | +$6.06M | 5.97% | 5 |
|
|
2022
Q4 | $36.7M | Buy |
227,047
+173
| +0.1% | +$26.5K | 5.67% | 5 |
|
|
2022
Q3 | $30.4M | Sell |
226,874
-3,804
| -2% | -$546K | 5.25% | 6 |
|
|
2022
Q2 | $35.3M | Buy |
230,678
+38,307
| +20% | +$5.85M | 6.01% | 4 |
|
|
2022
Q1 | $31.2M | Buy |
192,371
+91
| +0% | +$13.2K | 4.7% | 7 |
|
|
2021
Q4 | $26M | Buy |
192,280
+177,222
| +1,177% | +$20.9M | 3.79% | 11 |
|
|
2021
Q3 | $1.62M | Buy |
15,058
+835
| +6% | +$95.4K | 0.27% | 65 |
|
|
2021
Q2 | $1.6M | Buy |
14,223
+682
| +5% | +$76.8K | 0.27% | 65 |
|
|
2021
Q1 | $1.47M | Buy |
13,541
+1,657
| +14% | +$177K | 0.27% | 60 |
|
|
2020
Q4 | $1.27M | Buy |
11,884
+1,368
| +13% | +$131K | 0.24% | 54 |
|
|
2020
Q3 | $921K | Buy |
10,516
+5,820
| +124% | +$548K | 0.19% | 53 |
|
|
2020
Q2 | $461K | Buy |
4,696
+4,336
| +1,204% | +$382K | 0.11% | 71 |
|
|
2020
Q1 | $27K | Sell |
360
-26
| -7% | -$2.21K | 0.01% | 170 |
|
|
2019
Q4 | $34K | Sell |
386
-44
| -10% | -$3.65K | 0.01% | 180 |
|
|
2019
Q3 | $33K | Buy |
430
+28
| +7% | +$1.92K | 0.01% | 179 |
|
|
2019
Q2 | $29K | Sell |
402
-17
| -4% | -$1.34K | 0.01% | 174 |
|
|
2019
Q1 | $34K | Buy |
419
+6
| +1% | +$491 | 0.01% | 166 |
|
|
2018
Q4 | $38K | Buy |
413
+65
| +19% | +$5.72K | 0.01% | 167 |
|
|
2018
Q3 | $33K | Buy |
348
+46
| +15% | +$4.36K | 0.01% | 173 |
|
|
2018
Q2 | $28K | Hold |
302
| – | – | 0.01% | 183 |
|
|
2018
Q1 | $29K | Hold |
302
| – | – | 0.01% | 182 |
|
|
2017
Q4 | $29K | Hold |
302
| – | – | 0.01% | 189 |
|
|
2017
Q3 | $27K | Hold |
302
| – | – | 0.01% | 187 |
|
|
2017
Q2 | $22K | Hold |
302
| – | – | 0.01% | 198 |
|
|
2017
Q1 | $20K | Hold |
302
| – | – | 0.01% | 202 |
|
|
2016
Q4 | $19K | Buy |
302
+202
| +202% | +$12.3K | 0.01% | 196 |
|
|
2016
Q3 | $6K | Hold |
100
| – | – | ﹤0.01% | 262 |
|
|
2016
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 260 |
|
|
2016
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 247 |
|
|
2015
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 260 |
|
|
2015
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 262 |
|
|
2015
Q2 | $7K | Hold |
100
| – | – | ﹤0.01% | 329 |
|
|
2015
Q1 | $6K | Sell |
100
-115
| -53% | -$6.95K | ﹤0.01% | 327 |
|
|
2014
Q4 | $14K | Buy |
+215
| New | +$13.6K | 0.01% | 257 |
|
Other funds holding ABBV
MV Capital Management's ABBV Position: Q2 2026 in Review
MV Capital Management increased its AbbVie (ABBV) stake by 0.25% in Q2 2026, buying an estimated $148K and bringing the position to 271,250 shares worth $68.3M. The position accounts for 6.05% of the portfolio, ranked #4.
MV Capital Management first reported a position in ABBV in Q4 2014 and has held it in 47 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- MV Capital Management held 271,250 shares of AbbVie worth $68.3M as of Q2 2026.
- MV Capital Management bought 688 AbbVie shares in Q2 2026, an estimated $148K.
- AbbVie made up 6.05% of MV Capital Management's portfolio in Q2 2026, its #4 holding.
- MV Capital Management first reported a position in AbbVie in Q4 2014 and has held it in 47 quarters since.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.